Back
IVXO
Invion Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 456.75%
Annual Growth
4 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
3
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Invion Limited - Option Expiring 30-Jun-2027
📈 Performance
Price History
+1650.00%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.04
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IVXO
3
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in IVXO
N/A
IVXO investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
29%
Less than 50k
71%
👶 Age of investors
18 - 25
33%
26 - 34
35 - 90
67%
🙋 Legal gender of investors
Female
67%
Male
33%
Pearlers who invest in IVXO also invest in...
Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for cancers, atherosclerosis, and infectious diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-02-15. The firm is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The firm is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. The company holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.
🙌 Performance (5Yr p.a)
202.22%
📊 Share price
$0.10 AUD
📦 LOGISTICS
Pilbara Minerals Ltd. engages in the provision of exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm owns 100% of an independent hard-rock lithium operation, the Pilgangoora operation in Australia, and the Colina Project in Brazil. Its Pilgangoora operation is located 140 kilometers (kms) from Port Hedland in Western Australia’s resource rich Pilbara region on Nyamal and Kariyarra Country. Spodumene concentrate from its Pilgangoora operation is shipped from Port Hedland, the bulk export port, to lithium chemical converters primarily in China. The firm's Colina project is located 10 kms from the town of Salinas in the world class mining jurisdiction of Minas Gerais, Brazil. The firm is also integrated into the lithium value chain through its joint venture with POSCO in South Korea, which manufactures battery-grade lithium hydroxide.
🙌 Performance (5Yr p.a)
80.09%
📊 Share price
$1.73 AUD
🕊️ SOCIALLY AWARE
⛏️ MINING
HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.
🙌 Performance (5Yr p.a)
20.59%
📊 Share price
$15.22 AUD
🇦🇺 EX AUSTRALIA
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
Magnis Energy Technologies Ltd. is an integrated lithium-ion battery technology and materials company, which engages in the business of exploring, developing, and mining natural flake graphite. The company is headquartered in Sydney, New South Wales and currently employs 9 full-time employees. The company went IPO on 2005-10-25. Its subsidiary, Imperium3 New York Inc. (iM3NY), operates the Lithium-ion battery plant in Endicott, New York. iM3NY has commenced commercial production of Li ion cells and accelerating its ramp-up plans to produce 15,000 cells/day up to an annual production rate of 1.8 gigawatt hours with several binding offtakes already secured. Charge CCCV’s (C4V’s) proprietary Li-ion battery technology and discoveries are known for extending battery life, greater safety and charge performance. C4V’s also provides value chain solutions for Li ion battery manufacturing through cell design and engineering, cell fabrication process, qualification of raw materials supply chain and cell fabrication equipment supplier, blueprint of plants and engaging with engineering, procurement and construction (EPC) contractors.
🙌 Performance (5Yr p.a)
-16.18%
📊 Share price
$0.04 AUD
⛏️ MINING
Want more shares? Try these...